Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $1.36 billion. The enterprise value is $1.33 billion.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 353.82 million shares outstanding. The number of shares has increased by 15.98% in one year.
| Current Share Class | 353.82M |
| Shares Outstanding | 353.82M |
| Shares Change (YoY) | +15.98% |
| Shares Change (QoQ) | +3.62% |
| Owned by Insiders (%) | 12.30% |
| Owned by Institutions (%) | 31.40% |
| Float | 181.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 180.73 |
| Forward PS | 12.78 |
| PB Ratio | 32.37 |
| P/TBV Ratio | 58.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 211.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 2.35.
| Current Ratio | 4.04 |
| Quick Ratio | 3.81 |
| Debt / Equity | 2.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -119.24 |
Financial Efficiency
Return on equity (ROE) is -507.72% and return on invested capital (ROIC) is -66.90%.
| Return on Equity (ROE) | -507.72% |
| Return on Assets (ROA) | -52.83% |
| Return on Invested Capital (ROIC) | -66.90% |
| Return on Capital Employed (ROCE) | -77.35% |
| Revenue Per Employee | $44,119 |
| Profits Per Employee | -$2.98M |
| Employee Count | 143 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -84,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +321.16% in the last 52 weeks. The beta is 1.16, so Precigen's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | +321.16% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 2.44 |
| Relative Strength Index (RSI) | 46.39 |
| Average Volume (20 Days) | 4,818,478 |
Short Selling Information
The latest short interest is 28.88 million, so 8.16% of the outstanding shares have been sold short.
| Short Interest | 28.88M |
| Short Previous Month | 34.33M |
| Short % of Shares Out | 8.16% |
| Short % of Float | 15.92% |
| Short Ratio (days to cover) | 7.04 |
Income Statement
In the last 12 months, Precigen had revenue of $6.31 million and -$425.87 million in losses. Loss per share was -$1.43.
| Revenue | 6.31M |
| Gross Profit | -44.19M |
| Operating Income | -107.67M |
| Pretax Income | -246.95M |
| Net Income | -425.87M |
| EBITDA | -104.95M |
| EBIT | -107.67M |
| Loss Per Share | -$1.43 |
Full Income StatementBalance Sheet
The company has $121.14 million in cash and $98.19 million in debt, giving a net cash position of $22.94 million or $0.06 per share.
| Cash & Cash Equivalents | 121.14M |
| Total Debt | 98.19M |
| Net Cash | 22.94M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 41.87M |
| Book Value Per Share | 0.12 |
| Working Capital | 97.53M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$72.61 million and capital expenditures -$3.01 million, giving a free cash flow of -$75.62 million.
| Operating Cash Flow | -72.61M |
| Capital Expenditures | -3.01M |
| Free Cash Flow | -75.62M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,706.63% |
| Pretax Margin | -3,914.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.98% |
| Shareholder Yield | -15.98% |
| Earnings Yield | -31.43% |
| FCF Yield | -5.58% |
Analyst Forecast
The average price target for Precigen is $7.67, which is 100.26% higher than the current price. The consensus rating is "Buy".
| Price Target | $7.67 |
| Price Target Difference | 100.26% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 159.33% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -18.02 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.02 |
| Piotroski F-Score | 4 |
